OTC · Biotechnology

Regen BioPharma, Inc. (RGBP) Stock

$0.00 OTC: RGBP Healthcare

Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States.

Valuation

MetricValue
Price$0.00
Market Cap$3155
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.22
EPS (TTM)$-0.02
52-Week High$0.05
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE16.67%
ROA-252.85%
ROCE16.22%
Gross Margin100.00%
Operating Margin-260.24%
Net Margin0.00%
Debt/Equity-0.17
Current Ratio0.05

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$0$0$-1.0M$0$0
Net Profit$-7.0M$2.0M$1.0M$-1.0M$-1.0M
EPS$-1.69$0.36$0.14$-0.16$-0.05
Op Margin-117.4%-144.4%-290.4%-176.3%-143.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$1.0M$0$0$0
Total Liabilities$15.0M$9.0M$5.0M$5.0M$7.0M
Cash$1.0M$0$0$0$0
Borrowings$4.0M$1.0M$1.0M$1.0M$1.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$-1.0M$0$-1.0M$0
Investing Cash Flow$1.0M$0$0$0$0
Financing Cash Flow$1.0M$0$0$1.0M$0
Net Cash Flow$1.0M$-1.0M$0$0$0
Free Cash Flow$-1.0M$-1.0M$0$-1.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.75
FCF Yield-15123.84%
Quick Ratio0.05
Interest Coverage-4.16
Return 1Y-99.83%
Return 3Y-99.99%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CBDGTHC Farmaceuticals, Inc. $0.03 +0.00% 46.50 $505872 0.00%
CHNXFChitogenX Inc. $0.01 +0.00% -0.23 $627628 0.00%
DPATDental Patient Care America, Inc. $0.04 +0.00% 1.74 $1.01M 0.00%
IPIXInnovation Pharmaceuticals Inc. $0.00 — -0.32 $1.04M 0.00%
LVTTFLevitee Labs Inc. $0.00 — -0.03 $369155 0.00%

About Regen BioPharma, Inc.

Regen BioPharma, Inc. is a company dedicated to advancing regenerative medicine within the United States. It actively researches and identifies small molecule compounds designed to modulate the NR2F6 gene. This modulation is strategically aimed at activating immune cells for oncology treatments and suppressing them for autoimmune conditions. Its therapeutic pipeline and product development are currently in their initial phases. Established in 2012, the firm operates from its headquarters in La Mesa, California.

Regen BioPharma, Inc. (RGBP) stock trades at $0.00 with a market capitalization of $3155. The stock is valued at price-to-book of 0.00, price-to-sales of 0.22. Over the past 52 weeks the stock has ranged between $0.00 and $0.05, and currently trades 100.0% below its 52-week high.

On profitability, Regen BioPharma, Inc. generates a return on equity (ROE) of 16.67% (not meaningful, as shareholders' equity is negative), return on capital employed of 16.22%, an operating margin of -260.24%.

Official website: www.regenbiopharmainc.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1182.62 +0.28% JNJ Johnson & Johnson $263.73 +0.88% ABBV AbbVie Inc. $281.04 +1.65% MRK Merck & Company, Inc. Common Stock (new) $145.45 -0.10% UNH UnitedHealth Group Incorporated Common Stock (DE) $378.52 -0.21% NVS Novartis AG $143.84 +0.06% AZN AstraZeneca PLC $158.33 -0.55% TMO Thermo Fisher Scientific Inc $662.24 +0.64% AMGN Amgen Inc. $417.57 +0.65% GILD Gilead Sciences, Inc. $150.43 -0.49% ABT Abbott Laboratories $101.82 +2.23% NVO Novo Nordisk A/S $38.58 -0.16%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.